Lilly Analyzes Medicare Rx; Medicaid Changes May Be Big Plus
Executive Summary
The transfer of seniors who currently receive drug benefits under Medicaid into the new Medicare drug benefit may mean that private managed care purchasers will have enhanced leverage in price negotiations with manufacturers, Lilly CEO Sidney Taurel suggested
You may also be interested in...
Lilly Sees Benefit From Medicare Rx In Short Term, But Risk For Zyprexa
Lilly expects a "modest benefit" from implementation of Medicare Part D that could later be offset by increased pricing pressures
Lilly Sees Benefit From Medicare Rx In Short Term, But Risk For Zyprexa
Lilly expects a "modest benefit" from implementation of Medicare Part D that could later be offset by increased pricing pressures
Rx Industry Will Sell Medicare Bill; Card Launch Will Be First Test
PhRMA's efforts to support the roll-out of the Medicare prescription drug benefit will begin with the use of industry sales reps to deliver educational material, incoming Pharmaceutical Research & Manufacturers of America Chairman Miles White (Abbott) told the association's annual meeting in Palm Beach, Fla. April 3